Derralynn Hughes is currently a professor of experimental haematology at the University College London, clinical director of research and innovation at the Royal Free London, and co-clinical director of the North Central London Cancer Alliance. She also serves as the chair of the European working group on Gaucher disease. She has clinical responsibilities in the area of haematology and lysosomal storage disorders and is chair of the anaemia clinical practice group. She has published more than 150 papers in the area of macrophage biology and lysosomal storage disorders. Her research interests focus on the clinical and biological effects of bone disease and malignancy in Gaucher disease.